METROPOLITAN LIFE INSURANCE CO/NY - CONSTELLATION PHARMCETICLS I ownership

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$339,352
+69.7%
10,040
+17.5%
0.01%
+66.7%
Q1 2021$199,914
-18.8%
8,5470.0%0.00%
-25.0%
Q4 2020$246,154
+42.2%
8,5470.0%0.00%
+33.3%
Q3 2020$173,162
-32.6%
8,5470.0%0.00%
-40.0%
Q2 2020$256,837
+51.9%
8,547
+58.8%
0.01%
+25.0%
Q1 2020$169,125
-29.6%
5,381
+5.4%
0.00%0.0%
Q4 2019$240,4025,1030.00%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q3 2023
NameSharesValueWeighting ↓
Ponoi II Management, LLC 1,574,229$36,821,00028.20%
Ponoi Management, LLC 1,880,623$43,988,00025.87%
VR Adviser, LLC 4,016,873$93,955,00010.19%
Column Group LLC 2,626,631$61,437,0005.89%
Euclidean Capital LLC 554,325$12,966,0004.34%
GREAT POINT PARTNERS LLC 872,415$20,406,0004.22%
Venrock Management V, LLC 1,570,058$36,724,0003.76%
COMMODORE CAPITAL LP 368,448$8,618,0003.43%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 621,541$14,538,0001.90%
Bain Capital Life Sciences Investors, LLC 1,400,000$32,746,0001.86%
View complete list of CONSTELLATION PHARMCETICLS I shareholders